3869 — Hospital of China Share Price
- HK$939.72m
- HK$1.59bn
- CNY1.44bn
- 16
- 63
- 75
- 52
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.61 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.61 | ||
EV to EBITDA | 6.15 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 23.55% | ||
Return on Equity | -10.78% | ||
Operating Margin | 12.61% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 399.21 | 520.29 | 1,142.95 | 1,427.73 | 1,442.29 | n/a | n/a | 28.55% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +27.12 | +131.25 | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Hospital Corporation of China Ltd is a company principally engaged in operation and management of hospitals, provision of management services, supply chain services and other ancillary services to certain hospitals and sale of pharmaceutical products. The Company, along with its subsidiaries, operates its businesses through three segments. General hospital services segment is mainly engaged in hospital services including outpatient and inpatient services. Hospital management services segment is mainly involved in the provision of comprehensive management services including operation management services, supply chain services and other ancillary services. Sale of pharmaceutical products segment is mainly involved in sale of pharmaceutical products by the Company’s retail pharmacy. The Company mainly conducts its businesses in the domestic market.
Directors
- Shuai Chen CHM (46)
- Chuanbo Zang DGM (45)
- Wenzuo Lu EDR (71)
- Chengchuan Pu EDR (34)
- Yue Ding OTH (44)
- Meifen Le OTH (56)
- Jiayi Pang OTH (63)
- Wen Yang OTH (53)
- Min Yuchi OTH (63)
- Wing Yan Ho SEC
- Lu Liu NED
- Wenting Shi NED (31)
- Nan Wang NED
- Jinxue Dang NID (65)
- Luwen Shi NID (57)
- Xiangliang Zhou NID (36)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 21st, 2014
- Public Since
- March 16th, 2017
- No. of Employees
- 1,841
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 138,194,000

- Address
- 1602, Tower B, Jin Qiu International, BEIJING
- Web
- http://www.hcclhealthcare.com/
- Phone
- Auditors
- KPMG
Upcoming Events for 3869
Similar to 3869
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:10 UTC, shares in Hospital of China are trading at HK$6.80. This share price information is delayed by 15 minutes.
Shares in Hospital of China last closed at HK$6.80 and the price had moved by +6.25% over the past 365 days. In terms of relative price strength the Hospital of China share price has outperformed the FTSE Developed Asia Pacific Index by +7.46% over the past year.
There is no consensus recommendation for this security.
Find out moreHospital of China does not currently pay a dividend.
Hospital of China does not currently pay a dividend.
Hospital of China does not currently pay a dividend.
To buy shares in Hospital of China you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$6.80, shares in Hospital of China had a market capitalisation of HK$939.72m.
Here are the trading details for Hospital of China:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 3869
Based on an overall assessment of its quality, value and momentum Hospital of China is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hospital of China. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +54.96%.
As of the last closing price of HK$6.80, shares in Hospital of China were trading +17.26% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hospital of China PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$6.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Hospital of China's management team is headed by:
- Shuai Chen - CHM
- Chuanbo Zang - DGM
- Wenzuo Lu - EDR
- Chengchuan Pu - EDR
- Yue Ding - OTH
- Meifen Le - OTH
- Jiayi Pang - OTH
- Wen Yang - OTH
- Min Yuchi - OTH
- Wing Yan Ho - SEC
- Lu Liu - NED
- Wenting Shi - NED
- Nan Wang - NED
- Jinxue Dang - NID
- Luwen Shi - NID
- Xiangliang Zhou - NID